Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Dec;144(6):524-536.
doi: 10.1111/acps.13365. Epub 2021 Sep 16.

Adiposity in schizophrenia: A systematic review and meta-analysis

Emily Smith  1   2 , Raghunath Singh  1 , Jiwon Lee  1   2 , Laura Colucci  1   3 , Ariel Graff-Guerrero  1   2   4 , Gary Remington  1   2   4 , Margaret Hahn  1   2   4 , Sri Mahavir Agarwal  1   2   4
Affiliations
Meta-Analysis

Adiposity in schizophrenia: A systematic review and meta-analysis

Emily Smith et al. Acta Psychiatr Scand. 2021 Dec.

Abstract

Objective: Although a relationship between schizophrenia (SCZ), antipsychotic (AP) medication, and metabolic dysregulation is now well established, the effect of adiposity is less well understood. By synthesizing findings from imaging techniques that measure adiposity, our systematic review and meta-analysis (PROSPERO CRD42020192977) aims to determine the adiposity-related effects of illness and treatment in this patient population.

Methods: We searched MEDLINE, EMBASE, PsychINFO and Scopus for all relevant case-control and prospective longitudinal studies from inception until February 2021. Measures of adiposity including percent body fat (%BF), subcutaneous adipose tissue (SAT), and visceral adipose tissue (VAT) were analyzed as primary outcomes.

Results: Our search identified 29 articles that used imaging methods to quantify adiposity among patients with SCZ spectrum disorders. Analyses revealed that patients have greater %BF (mean difference (MD) = 3.09%; 95% CI: 0.75-5.44), SAT (MD = 24.29 cm2 ; 95% CI: 2.97-45.61) and VAT (MD = 33.73 cm2 , 95% CI: 4.19-63.27) compared to healthy controls. AP treatment was found to increase SAT (MD = 31.98 cm2 ; 95% CI: 11.33-52.64) and VAT (MD = 16.30 cm2 ; 95% CI: 8.17-24.44) with no effect on %BF. However, change in %BF was higher for AP-free/AP-naïve patients compared to treated patients.

Conclusion: Our findings indicate that patients with SCZ spectrum disorders have greater adiposity than healthy controls, which is increased by AP treatment. Young, AP-naïve patients may be particularly susceptible to this effect. Future studies should explore the effect of specific APs on adiposity and its relation to overall metabolic health.

Keywords: abdominal; adiposity; antipsychotic agents; intra-abdominal fat; schizophrenia spectrum and other psychotic disorders; subcutaneous fat.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005;150(6):1115-1121. 10.1016/j.ahj.2005.02.007.
    1. Vrbová K, Kamarádová D, Látalová K, et al. Self-stigma and adherence to medication in patients with psychotic disorders-cross-sectional study. Neuroendocrinol Lett. 2014;35(7):645-652. www.nel.edu. Accessed November 19, 2019.
    1. Werner F-M, Coveñas R. Safety of antipsychotic drugs: focus on therapeutic and adverse effects. Expert Opin Drug Saf. 2014;13(8):1031-1042. doi:10.1517/14740338.2014.935761.
    1. Pillinger T, Beck K, Gobjila C, Donocik JG, Jauhar S, Howes OD. Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74(3):261-269. 10.1001/jamapsychiatry.2016.3803.
    1. Suvisaari J, Keinänen J, Eskelinen S, Mantere O. Diabetes and Schizophrenia. Curr Diab Rep. 2016;16(2):16. 10.1007/s11892-015-0704-4.

Publication types